Navigation Links
Finasteride lowers risk of prostate cancer but increases risk of high-grade tumors

Finasteride prophylaxis appears to prevent or delay the onset of prostate cancer, however, finasteride may also accelerate the growth of high-grade cancers.
More than 18,000 men were randomized , age 55 or older to finasteride 5 mg/day or placebo. At baseline, digital rectal examination results were normal in all subjects, and prostate-specific antigen (PSA) levels were no more than 3.0 ng/mL. Among the 4368 men in the finasteride group treated for 7 years,// prostate cancer was detected in 18.4%, compared with 24.4% of the 4692 assigned to placebo group, a significant difference (p < 0.001). Tumors of Gleason grade 7, 8, 9, or 10 occurred in 37.0% of the graded tumors in the finasteride group and 22.2% of those in the placebo group (p = 0.005). Five men in each group died from prostate cancer.

Treatment was temporarily discontinued by 18.3% of subjects administered finasteride and 9.8% of those given placebo because of side effects. Finasteride was more likely to affect sexual functioning, whereas placebo was more likely to be associated with genitourinary effects.

For a man considering using this medication, the greater absolute reduction in the risk of prostate cancer must be weighed against the smaller absolute increase in the risk of high-grade disease,say doctors.

Researchers, suggests that "finasteride may have created an environment in which high-grade cancers that were less dependent on androgens for their growth had a competitive advantage."

According to doctors , "Finasteride does not seem to be an attractive agent for the chemoprevention of prostate cancer." However, they do not advocate discontinuation of the drug when used to treat urinary symptoms, so long as patients undergo careful monitoring.
'"/>




Page: 1

Related medicine news :

1. Finasteride lowers risk of prostate cancer but increases risk of high-grade tumors
2. Brisk Walking lowers memory loss in women
3. B Vitamin protects and lowers toxicity of Arthritis Drug
4. Estrogen lowers cancer risk
5. Lecithin lowers cholesterol absorption in body
6. Salt reduction lowers blood pressure
7. Exercise lowers Risk of Ovarian Cancer
8. Fish rich diet lowers leptin
9. Finasteride lowers risk of prostate cancer but increases risk of high-grade tumors
10. A Warning For Western Diet Followers!
11. Smoking lowers chances of surviving throat cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/20/2017)... FL (PRWEB) , ... January 20, 2017 , ... Source ... botanicals and 100 percent pure essential oils, announced the company had a successful visit ... , The annual ECRM event gives companies that work in the nutritional, sports and ...
(Date:1/20/2017)... ... 20, 2017 , ... International Protein, a company based out of Australia that ... the January ECRM trade show in Hilton Head, SC. , International Protein was ... create a line of products that would elevate her fitness regime. At this ECRM ...
(Date:1/20/2017)... ... January 20, 2017 , ... “The Angel”: a ... has set out for each of his children. “The Angel” is the creation of ... Music in New York City, and impassioned writer. , When asked of her new ...
(Date:1/20/2017)... ... ... “Journey to Christmas:” a beautiful and enchanting tale that teaches children the true meaning of ... three in Oklahoma City, and a devoted woman of faith. , “Becoming a parent ... the back of my mind for years, but actually doing it might have been a ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... E-learning system for Clinical and Regulatory education for Physicians, Physician Advisors, Case ... successful education methodology of Disease Specific Documentation Improvement. , The Aerolib Learning ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... , Jan. 19, 2017  Sensus Healthcare, Inc. ... company specializing in the treatment of non-melanoma skin ... with superficial radiation therapy, today announced that it ... 2016 financial results on Thursday, February 2, 2017 after ... hold a conference call with the investment community ...
(Date:1/19/2017)... England , January 19, 2017 ... and Otsuka in the Milner Therapeutics Consortium   ... scientists in Cambridge   ... (NYSE: PFE ) as a partner to ... the Consortium, which enables the efficient transfer of materials ...
(Date:1/19/2017)... 18, 2017 , , Marks E-QURE ... distribution agreement, following similar agreements in Israel ... care is $2 5 billion global ... Corp. (OTCQB: EQUR), a leader in medical devices for the treatment of advanced ... Equipos Médicos S.A.S. (TeckMedica) in Colombia for the Company,s ...
Breaking Medicine Technology: